The global DNA sequencing products market size reached US$ 6.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.4 Billion by 2028, exhibiting a growth rate (CAGR) of 9.76% during 2023-2028.
DNA sequencing is the process used for calculating the precise sequence of the four nucleotide bases within a DNA molecule, namely, cytosine, adenine, thymine and guanine. It plays an important role in mapping out the human genome as well as helps in various applied research applications. In line with this, DNA sequencing products are gaining popularity in the pharmaceutical industry as they assist researchers in understanding complex diseases and, in turn, develop personalised medicines for patients. Additionally, DNA profiling has become an integral part of forensic science as these profiles enable investigators to identify and distinguish multiple samples from a pool of DNA.
Global DNA Sequencing Products Market Drivers:
Genome mapping and sequencing of microorganisms have enabled agriculturists to use them for crops and food plants. Over the past few years, specific genes of bacteria have been used in food plants to improve their resistance against insects and pests which has increased their productivity and nutritional value. In addition to this, genomes of several domesticated livestock animals, such as chicken, pig, cow, sheep, and horse, have also been partially or completely sequenced and proven to be useful in the production of livestock with enhanced quality of meat and milk.
The role of DNA sequencing in the in-vitro diagnostics market, particularly for point-of-care diagnostics, is expected to gain momentum. DNA sequencing enables the development of precision medicine in order to offer specific treatments or therapies to patients. It also provides various platforms that enable genetic sequencing and analysis of DNA data at the point-of-care with high accuracy and rapid diagnosis.
Researchers and instrument developers have produced an array of DNA sequencing technologies which offer faster sequencing with higher accuracy at lower costs. For instance, one of the primary market players in the field, Illumina, has launched a system that consists of 10 ultra-high-throughput sequencers and can sequence about 18,000 human genomes per year.
Researchers are now using innovative technologies for genome mapping that take lesser time for completion. Other than this, the reduction in sequencing costs has led many companies to invest in R&D activities and offer cost-effective solutions such as whole genome sequencing, de novo sequencing and specific disease diagnosis.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global DNA sequencing products market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on product type, application and end-user.
Breakup by Product Type:
Consumables and Reagents
On the basis of the product type, the market has been segmented into consumables and reagents, and equipments. Currently, consumables and reagents represent the largest segment as they generate a higher return-on-investments.
Breakup by Application:
DNA sequencing products find applications across various sectors including biomarkers, diagnostics, reproductive health, personalised medicine, forensics and others. Amongst these, biomarkers are the most popular application segment of DNA sequencing products as they help in predicting treatment outcomes.
Breakup by End-User:
Academic and Government Research Institutes
Pharmaceutical and Biotechnology Companies
Hospitals and Clinics
Based on the end-user, the market has been segregated into academic and government research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and others. At present, DNA sequencing is majorly being used in academic and government research institutes owing to the presence of a large number of research and development projects which involve the practical implementation of data analysis and next-generation sequencing.
Middle East and Africa
On a geographical front, North America accounts for majority of the total global DNA sequencing products market. This can be accredited to the growing geriatric population, prevalence of several chronic diseases and presence of prominent drug manufacturers in the region.
The nature of the market is fragmented with the presence of numerous small and large manufacturers who compete in terms of prices and quality. Some of the leading players operating in the market are:
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
Pacific Biosciences of California, Inc.
Base Year of the Analysis
Product Type, Application, End-User, Region
Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Illumina Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Pacific Biosciences of California, Inc. and Beckman Coulter
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The global DNA sequencing products market was valued at US$ 6.3 Billion in 2022.
We expect the global DNA sequencing products market to exhibit a CAGR of 9.76% during 2023-2028.
The increasing adoption of DNA sequencing products in mapping out the human genome, as it assists researchers in understanding complex diseases and developing personalized medicines for patients, is primarily driving the global DNA sequencing products market.
The sudden outbreak of the COVID-19 pandemic has led to the rising demand for DNA sequencing products in the development of therapeutics and diagnostics of the coronavirus infection.
Based on the product type, the global DNA sequencing products market can be categorized into consumables and reagents and equipment. Currently, consumables and reagents hold the largest market share.
Based on the application, the global DNA sequencing products market has been segmented into biomarkers, diagnostics, reproductive health, forensics, personalized medicine, and others. Among these, biomarkers currently exhibit a clear dominance in the market.
Based on the end-user, the global DNA sequencing products market can be bifurcated into academic and government research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and others. Currently, academic and government research institutes account for the majority of the total market share.
On a regional level, the market has been classified into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global DNA sequencing products market include Illumina Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Pacific Biosciences of California, Inc., Beckman Coulter, etc.
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.